People

Bramie Lenhoff

Principal investigator

lenhoff@udel.edu

Bramie is the Allan P. Colburn Professor in the Department of Chemical Engineering at the University of Delaware (UD). In addition to the research described on this and other pages, he has been involved in several other activities at UD, including being chair of the department, director of the COBRE on Membrane Protein Production and Characterization, associate director of the Chemistry-Biology Interface Training Program, a faculty member in the Center for Molecular and Engineering Thermodynamics and a member of the management team of the Delaware INBRE. Further information is available in his CV. He has taught a wide variety of courses in the undergraduate and graduate programs in chemical engineering.

Vijesh Kumar

Postdoctoral researcher

vijesh@udel.edu

Correct prediction of protein elution behavior on an ion-exchange resin depends largely on an accurate description of the binding models as well as transport properties of resin bead. At low coverages, several widely-used isotherms approach linear behavior, but at higher surface coverages, encountered during saturation loading, the deviation from linearity and approach to a plateau level deviate among different models. This behavior leads to different peak shapes when saturation levels of loading are reached. The elution peak shape is found to be dependent not only upon the protein size and its physiological properties but also on details of the resin morphology. The aim of this project is to explore the in-depth understanding of protein behavior on ion exchange resins so as to build a robust mechanistic model which can be useful in the wide domain of process variability and hence applicable to industrial setup.

Anvar Samadzoda

Graduate student

anvars@udel.edu

Anvar’s research focuses on the development of a mechanistic understanding of crystallization of membrane proteins. In his work, he has used two model proteins – reaction center from R. sphaeroides and OmpX expressed in E. coli – with their respective crystallization conditions and utilized a variety of biophysical and colloid science techniques in order to extensively characterize crystal-yielding solutions.

Anvar graduated from the Middle East Technical University, Anvara, Turkey with a BS in Chemical Engineering in 2007. He worked in consumer goods industry as a Formulations and Processing R&D Engineer for about 2 years before joining the lab.

 

Ohnmar Khanal

Graduate student

okhanal@udel.edu

Depth filtration, displacement chromatography, and mAb/host cell protein interactions.

 

Younghoon Oh

Graduate student

yhoh@udel.edu

Host-cell proteins (HCPs) generated from the host cells in monoclonal antibody (mAb) manufacturing – usually Chinese hamster ovary (CHO) cells – must be removed during product purification. Some HCPs remaining in the final drug substance may cause problems even at trace levels: 1) immunogenic responses; 2) in vivo reactions; 3) product degradation. Younghoon’s research aims to develop a comprehensive approach to identify and remove CHO HCPs, which are problematic in downstream processing of mAbs, by employing the following techniques: 1) LC-MS based proteomic analysis; 2) cross interaction chromatography (CIC); 3) recombinant protein expression of individual problematic HCPs.

Younghoon received a Bachelor and Master’s degree in Chemical and Biomolecular Engineering from Sogang University. Before joining the group, he worked for the Research Center for Bio-based Chemistry at the Korea Research Institute of Chemical Technology as a researcher (tenure track). Google Scholar profile.

 

Chase Herman

Graduate student

cherman@udel.edu

Biopharmaceuticals have enabled qualitatively improved medical treatments over the past half century. Well over 300 protein therapeutics are on the market today, and hundreds are estimated to be in development pipelines. Coupled with their rapid development is a need to efficiently design and optimize the downstream processes for purifying proteins. Chromatography is essential to this purification, but the design of preparative chromatographic separations is largely empirical. Mechanistic models could improve the design of preparative separations, but their utility is often limited by insufficient adsorption equilibrium information. My research focuses on predicting protein adsorption equilibrium from proteomics data. Our goal is to use these predictions to model the retention of host cell protein impurities in flow-through polishing operations.

 

Xutao (Steve) Shi

Graduate student

Co-advisor: Norman J. Wagner

shixt@udel.edu

Biopharmaceuticals, in particular, monoclonal antibodies (mAbs), have seen major growth in development and market value over the last few decades. Their importance in a wide variety of clinical settings and treatments has led to extensive research of their storage, transportation, and clinical delivery. Due to the poor oral bioavailability, biopharmaceuticals are usually delivered by parenteral methods such as subcutaneous injection that leads to a length and frequent administration schedule. One route to reduce this administrative burden is the controlled release, in which a polymeric implant encapsulating the drug is placed into the patients and releases drug particles over a therapeutic window. However, the efficacy and reliability of such a delivery system rely on the stringent control of the drug release profile. A minimum quantity of drug release per day is generally required to maintain the bioavailability for sufficient biotherapeutic effect, yet any excessive releases may lead to immunogenic side effects or a compromised potency. Moreover, due to the number of physio-chemical processes involved and the definitive requirement on the drug release profile, fine-tuning of the release behaviors is not a trivial task and the development of such controlled-release systems is often resource-intensive and requires several long-term experimental studies. Therefore, this thesis research aims to combine experimental and modeling approaches to develop effective and predictive methods for designing such controlled release devices. Specifically, modeling work will entail the formulation of a physics-relevant model that is applicable and predictive across various release systems and environments. And the experimental component involves a characterization of the release devices and their release mechanisms across various system parameters and environments.

 

Kerri Mendola

Undergraduate researcher

kmendola@udel.edu

Monoclonal antibodies are a major class of therapeutic proteins used to treat diseases such as cancer. Some host cell proteins bind to these therapeutic proteins and negatively impact the drug product’s stability and effectiveness.  My research focuses on one of these host cell proteins, lipoprotein lipase, a persistent hitchhiking protein in the process of purifying monoclonal antibodies for drug use.  My goal is to produce lipoprotein lipase in order to characterize the interactions between the monoclonal antibodies and the lipoprotein lipase.

 

Schuyler Reed

Undergraduate researcher

srreed@udel.edu

Training neural networks based on chromatography data including retention time, protein elution, and protein absorbance.

 

Group alumni

Sai Prasad Ganesh

Sai Prasad Ganesh

Former graduate student, MChE 2019

Sai completed his undergraduate degree at the University of Buffalo and did his graduate research in our group and the Wagner group. He completed his MChE degree in 2019.

Stijn Koshari

Stijn Koshari

Former graduate student, PhD 2018

Stijn came to UD as the first dual-degree Masters student from the Katholieke Universiteit Leuven in Belgium.  He stayed on for a PhD in our group and the Wagner group, which he completed in 2018. He is now at Glaxo SmithKline in the Philadelphia area.

Jing Guo

Jing Guo

Former postdoctoral researcher

Jing came to UD in 2016 after completing his PhD at the University of Virginia. His postdoc included projects in our group and in Prof. Kelvin Lee’s group. Jing moved to a position at Teva Pharmaceuticals in 2018.

Dan Greene

Dan Greene

Former graduate student, PhD 2016

After graduation Dan accepted a position at ReForm Biologics and in 2018 moved to Amgen in Cambridge, MA.
David Rosenman

David Rosenman

Former postdoctoral researcher

David received his PhD from Rensselaer Polytechnic in 2015 and worked in our group until 2016, when he accepted a position with Eurofins Lancaster Laboratories.
Tao Liu

Tao Liu

Former visiting graduate student

Tao spent a year with us in 2015-6 towards the end of his PhD thesis research at Zhejiang University in China, from which he graduated in 2017.
Jim Angelo

Jim Angelo

Former graduate student, PhD 2016

Jim completed his PhD in 2016 and joined the growing set of group alumni at Bristol-Myers Squibb in Devens, MA.
Rahul Bhambure

Rahul Bhambure

Former postdoctoral researcher

Rahul was a postdoc in our group after completing his PhD at IIT Delhi.  He returned to India in 2016 to take a position as a Scientist at the National Chemical Laboratory in Pune.
Amit Vaish

Amit Vaish

Former postdoctoral researcher

After completing his PhD at Penn State University, Amit was a postdoc at the National Institute of Standards and Technology before joining our group as a postdoc.  He is now at Amgen in Thousand Oaks, CA.
Kristin Valente

Kristin Valente

Former graduate student, PhD 2014

Kristin was employed by Merck before returning to UD for graduate school, where she was co-advised by Prof. Kelvin Lee. After graduation she rejoined Merck.
Nick Levy

Nick Levy

Former graduate student, PhD 2014

Nick, who was co-advised at UD by Prof. Kelvin Lee, is currently employed by GlaxoSmithKline in King of Prussia, PA.
Steve Traylor

Steve Traylor

Former graduate student, PhD 2013

Steve is another of our several group alumni currently employed by Bristol-Myers Squibb in Devens, MA.
Harun Koku

Harun Koku

Former graduate student, PhD 2011

Harun is an assistant professor of chemical engineering at the Middle East Technical University in Ankara, Turkey.
Leigh Quang

Leigh Quang

Former graduate student, MChE 2012

Leigh was co-advised at UD by Prof. Stanley Sandler. He is currently employed by Eastman Chemical in Chestertown, MD.
Brian Bowes

Brian Bowes

Former graduate student, PhD 2011

Brian is currently employed by Eli Lilly in Indianapolis, IN.
Kelley Kearns

Kelley Kearns

Former graduate student, PhD 2011

Kelley, who was co-advised by Prof. Eric Kaler, worked at Bristol-Myers Squibb in Syracuse, NY, before moving to Germany to take a position at Dynavax Technologies.  He is now back in the US working for Avitide in Lebanon, NH.
Rachael Lewus

Rachael Lewus

Former graduate student, PhD 2011

Rachael, who was co-advised by Prof. Stanley Sandler, is employed at MedImmune in Gaithersburg, MD.
Chris Gillespie

Chris Gillespie

Former graduate student, PhD 2011

Chris, who was co-advised by Prof. Eric Kaler, worked for EMD Millipore in Bedford, MA, for several years after graduating.  In 2018 he took a position with Immunogen in Waltham, MA.
Harvey Johnson

Harvey Johnson

Former postdoctoral researcher

Harvey teaches math and science at St. Andrews School in Middletown, DE.
Cristina Martin

Cristina Martin

Former postdoctoral researcher

Cristina completed her postdoc in summer 2010 and returned to her alma mater in Spain, where she teaches chemical engineering.
Bryan Berger

Bryan Berger

Former graduate student, PhD 2005

After graduation Bryan was a postdoc at the University of Pennsylvania for several years, but in 2009 accepted an assistant professorship at Lehigh University, where he studied membrane biophysics, biosurfactants, and synthetic biology. In 2017 he moved to the University of Virginia as an associate professor.
Carolina Bianco

Carolina Bianco

Former graduate student, PhD 2008

Carolina worked for Bayer HealthCare Pharmaceuticals in Berkeley, CA, after completing her thesis research, which was co-advised by Prof. Eric Kaler. She left the company to move to Germany, where she now resides.
Yu-Chia Cheng

Yu-Chia Cheng

Former graduate student, PhD 2007

Yu-Chia, who was co-advised by Prof. Stanley Sandler, currently resides in Taiwan.
André Dumetz

André Dumetz

Former graduate student, PhD 2007

Andre, whose research was co-advised by Prof. Eric Kaler, is currently employed by GlaxoSmithKline.
JJ Langford

JJ Langford

Former graduate student, PhD 2007

JJ returned to his native Tennessee after graduation and works at Process Engineering Associates.
Gabriella Santonicola

Gabriella Santonicola

Former graduate student, PhD 2007

Gabriella, who was co-advised by Prof. Eric Kaler, worked as a postdoc in Europe after graduation and is now an assistant professor at Sapienza University in Rome.
Peter M. Tessier

Peter M. Tessier

Former graduate student, PhD 2003

After graduating from Delaware, Pete completed a postdoctoral fellowship at the Whitehead Institute for Biomedical Research. In 2007 he accepted an assistant professorship in chemical engineering at Rensselaer Polytechnic Institute in Troy, NY. where his research included investigations into fundamental aspects of protein misfolding and aggregation. In 2017 he became the Albert M. Mattocks Professor of Pharmaceutical Sciences and Chemical Engineering at the University of Michigan.
Brian To

Brian To

Former graduate student, PhD 2006

After several years of employment at Merck and Co., Brian moved to the Bay area and joined Bayer HealthCare Pharmaceuticals in Berkeley, CA.  He is now at Boehringer Ingelheim in Fremont, CA.
Egor Trilisky

Egor Trilisky

Former graduate student, PhD 2009

Egor worked at Amgen in Seattle, WA, after graduation and subsequently moved to Takeda Vaccines in Bozeman, MT.
Xuankuo Xu

Xuankuo Xu

Former graduate student, PhD 2008

Xuankuo took a position at Bristol-Myers Squibb in Syracuse, NY, after graduation, and subsequently became the first of our several group alumni at the BMS site in Devens, MA.